Newsroom

April 2, 2025 5:46 PM

EDT

•

NASHVILLE, TN

TuneHatch’s $1 Million Giveback to Independent Artists: Giving Control and Cash to its Musicians in 2025, Onward

TuneHatch, the next-gen show management platform dedicated to making live music and entertainment more transparent, efficient, and profitable for artists, promoters, and venues alike, just announced its groundbreaking “Built to Give Back” initiative, designed to boost earnings for the creative community during a time when every dollar counts. For all of 2025 and beyond, any artist or promoter that creates a ticket link on TuneHatch will get a cash bonus of up to $5 per ticket sold, paving the way for bolder, more profitable touring and concerts. Their venue “Built to Give Back” initiative will be announced in Summer 2025.

Putting Artists First

The concept behind “Built to Give Back” is simple: When you list a show on TuneHatch, for every ticket you sell, TuneHatch sends bonus cash back to your account. This extra money can be paid out to anyone on the line up after the show.

“We built TuneHatch because we believe that independent artists deserve a fair shot at making a living doing what they love,” said Christal Hector, founder and CEO at TuneHatch. “Our ‘Built to Give Back’ initiative is an extension of that mission, ensuring our users can quickly and easily ticket their events while making more money to fuel their careers.”

In a landscape where fees can pile up and cut into earnings, especially for small and independent artists and organizers, TuneHatch is stepping in to give them the power to fund their careers and fuel their passion—at no cost!

$1 Million Giveback

TuneHatch boldly seeks to give back $1 million through this initiative. But how? Just 20 tickets sold can net artists $100 extra on a show. With 10,000 artists listing their shows, TuneHatch could give back over $1,000,000 this year alone.

The $1 million giveback is powered by the very people it’s designed to support. When artists and promoters choose to list their shows on TuneHatch, they’re not just increasing their own earnings—they’re fueling a system that gives back to the entire live music community. Like the classic “buy one, give one” movement, every show added helps grow the impact, turning everyday participation into meaningful change.

Why Support “Built to Give Back”?

Boost community growth: By putting money back into the hands of artists, TuneHatch fosters a community where artists and organizers can focus on building memorable experiences that bring people together.
Support emerging artists: For up-and-coming performers, budgets are tight and every dollar counts. Being able to make more money on each ticket sale gives new talent the boost they need to refine their art, attract new fans, and advance their careers.
Sustainable growth: When artists and organizers make more revenue, they can reinvest in marketing, production, and future shows. This cycle of reinvestment leads to thriving events that benefit both artists and fans alike.

How It Works

Sign up or log In: Create a free TuneHatch account or log in to your existing one.
Create a listing: Post your upcoming event, whether a concert, comedy show, or any other live performance event.
Get paid: Watch as you make extra money on every ticket sold, in real time from your artist dashboard on TuneHatch—you can pay yourself and your lineup immediately after the show concludes. No waiting period, no extra fees!
Tell a friend: Help other artists make more money by sharing your listings and telling them about the “Built to Give Back” initiative.

For a detailed explanation of how it works, visit the TuneHatch “Built to Give Back” resource page.

The Road Ahead

With the launch of “Built to Give Back,” TuneHatch cements its commitment to nurturing a thriving community of artists and organizers who work tirelessly to bring people together through unforgettable shows. This campaign isn’t just about the money—it’s about sparking a movement that challenges ticketing norms, for the benefit of the creative community. When more creators can invest in their passion, fans benefit from more high-quality, diverse events.

“TuneHatch is dedicated to bridging the gap between artists, their fans, and the rest of the music ecosystem,” added Will Pellerin, a Nashville-based TuneHatch artist and former contestant on The Voice. “When artists and organizers keep more of their earnings, they invest back into the creative process. Everyone—from the organizer to the attendee—wins.”

Join the Movement

TuneHatch’s “Built to Give Back” Campaign aims to bolster an already passionate community of live music artists and organizers, helping them focus on what truly matters: creating unforgettable experiences for their fans.

Sign up: If you’re an artist or event organizer looking to earn more on your shows, sign up on TuneHatch for free, today.
List an event: It takes less than 5 minutes to launch your event and start getting paid.
Tell a friend: Share the news and amplify the impact.

Join TuneHatch’s “Built to Give Back” initiative for free today!

About TuneHatch

TuneHatch is a live event platform that makes it easy for artists, promoters, and venues to book, promote, and ticket shows—all in one place. Designed for transparency, speed, and simplicity, TuneHatch helps performers and venues spend less time on admin and logistics and more time doing what they love: putting on great shows. With accessible tools and a community-first approach, our “Built to Give Back” initiative reflects our mission to support independent talent and bring people together through unforgettable live experiences. Learn more at tunehatch.com.

Media Contact

Christal Hector
media@tunehatch.com

April 2, 2025 9:53 AM

EDT

•

NEW YORK, NY

TrialKit Launches AI-Powered Legal Discovery Platform, Secures $4.25M Seed Funding to Transform Criminal Defense

TrialKit, an AI-powered discovery platform built for criminal defense attorneys, today announced its public launch alongside a $4.25 million seed round led by UpWest, with participation from 97212 Ventures, Kaedan Capital, and NYU Law’s Entrepreneurship & Venture Capital Program. The company provides an end-to-end, AI-native legal discovery platform designed specifically to help defense attorneys manage the overwhelming volume of digital evidence in modern criminal cases.

“I’ve been in the shoes of the attorney at 2 a.m. trying to find the one moment in a body cam that could change everything. TrialKit was born out of that experience — to help attorneys cut through the chaos, stay organized and focus on building the strongest defense possible,” said Ariel Deshe, co-founder and CEO of TrialKit.

Over the past decade, the volume of digital evidence in criminal cases has exploded, dramatically outpacing the tools attorneys have available. In Colorado, for example, public defenders have reported discovery volume growing by 4,500%. That growth has added pressure to an already overburdened system, where attorneys need far more time and resources to properly review discovery, prepare cases, and advise clients at every stage.

TrialKit streamlines legal discovery by leveraging AI to analyze massive datasets in minutes, rather than weeks or months. Specific features include:

Automated Organization & Categorization: Automatically ingests and labels messy, unstructured discovery.
AI-Powered Search Across All File Types: Converts and translates all files (videos, PDFs, audio, etc.) into searchable text.
Entity Extraction & Cross-Reference Mapping: Identifies people, locations, and times across thousands of files.
Facial Recognition for Video Review: Detects and catalogs faces in body-worn camera footage and surveillance video.
Interactive Workstation for Trial Prep: Integrates tools for note-taking, fact mapping, and witness preparation, allowing attorneys to analyze discovery and get case-ready in one secure workspace.

Already in use by more than 20 leading criminal defense firms and in public criminal defense cases across the U.S., TrialKit has received strong early traction.

“TrialKit fundamentally transforms discovery,” said Jason Kosloski, Partner at Koslowski Law. “As even the most routine cases are quickly ballooning in size, TrialKit is a force-multiplier that saves hours and hours of organizing and makes the process of reviewing and finding connections within discovery infinitely easier.”

“The burden of discovery is one of the biggest challenges in today’s criminal justice system, and TrialKit has created a truly groundbreaking solution,” said Gil Ben-Artzy, founding partner at UpWest. “By bringing AI-powered intelligence to the legal field, they’re helping level the playing field for defense attorneys who have been operating at a disadvantage for far too long.”

TrialKit is now available to criminal defense firms across the country. Legal professionals interested in learning more can request a demo at TrialKit.ai.

About TrialKit

Built by attorneys for attorneys, TrialKit empowers litigators by transforming overwhelming discovery into a dynamic, searchable case file. With AI-driven analysis, fact visualization and seamless collaboration, attorneys can surface key evidence faster, reduce costs and build stronger defenses within a secure, intuitive platform. Founded in 2023 by former public defender Ariel Deshe, TrialKit has raised $4.25 million from UpWest, 97212 Ventures, Kaedan Capital, and NYU Law’s Entrepreneurship & Venture Capital Program. Today, law firms across the U.S. rely on TrialKit to streamline discovery, strengthen their defenses, and meet the growing demands of digital evidence. For more information, visit https://www.trialkit.ai.

Media Contact

Katy Goldstein
katy@katygoldsteincomms.com

April 2, 2025 9:44 AM

EDT

•

ASHBURN, VA

Quoin Reports Clinically Meaningful Whole Body Response to QRX003 in Pediatric Netherton Syndrome; Second Patient Cleared for Dosing

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced additional encouraging clinical findings from its ongoing investigator-led study in pediatric Netherton syndrome (NS). After six weeks of continuous whole body treatment with QRX003, the enrolled pediatric patient continues to demonstrate significant clinical benefit, including visibly healed skin, sustained relief from symptoms, and elimination of the need for previously required medications.

Specifically, the patient’s skin remains almost entirely healed, underscoring the durability of effect seen with ongoing daily use of QRX003. Importantly, the subject has not required prior medications such as antibiotics, antivirals, antihistamines, or glucocorticoids. The patient’s pruritus (itch) remains virtually eliminated, leading to the continuation of restful, uninterrupted sleep—described by the study team as the first sustained period of undisturbed sleep in the patient’s life. No adverse events have been reported after six weeks of full body exposure to QRX003.

Based on these results, Quoin has received approval to initiate testing of a second pediatric patient under the same whole body treatment protocol.

Dr. Michael Myers, CEO of Quoin, commented: “We’re very encouraged to see continued improvement in this first pediatric patient following whole body application of QRX003. Her skin is now almost completely healed, and she remains free from previously required medications. Most notably, the pruritus that has severely impacted her quality of life since birth is now nearly eliminated, and she is finally experiencing uninterrupted sleep without the need for sedatives.

These outcomes provide strong evidence that QRX003 may be addressing the underlying pathology of Netherton syndrome—not just managing symptoms. The absence of adverse events after six weeks of full-body exposure is also highly encouraging. With approval now granted to initiate treatment in a second pediatric subject, we look forward to continuing this important study and reporting further updates.”

About Quoin Pharmaceuticals

Quoin Pharmaceuticals Ltd. is a late clinical-stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises four products in development that collectively have the potential to target a broad number of rare and orphan indications, including Netherton syndrome, peeling skin syndrome, SAM syndrome, palmoplantar keratoderma, scleroderma, epidermolysis bullosa, microcystic lymphatic malformations, venous malformations, angiofibroma, and others. For more information, visit: www.quoinpharma.com or LinkedIn for updates.

Cautionary Note Regarding Forward Looking Statements

The Company cautions that statements in this press release that are not descriptions of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words referencing future events or circumstances, such as “expect,” “intend,” “hope,” “plan,” “potential,” “anticipate,” “look forward,” “believe,” “may,” and “will,” among others. All statements that reflect the Company’s expectations, assumptions, projections, beliefs, or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to: the potential efficacy of QRX003 as a treatment for Netherton syndrome; testing expected to commence in a few weeks on a second pediatric patient; continue with our plans to further expand this study to include additional pediatric subjects; and Quoin’s products in development collectively having the potential to target a broad number of rare and orphan indications, including Netherton syndrome, peeling skin syndrome, SAM syndrome, palmoplantar keratoderma, scleroderma, epidermolysis bullosa, microcystic lymphatic malformations, venous malformations, angiofibroma and others. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon the Company’s current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties including, but not limited to, the Company’s ability to deliver a safe and effective treatment for Netherton syndrome; whether the Company’s studies successfully generate data that is sufficiently robust and comprehensive to support an NDA filing for QRX003 as an approved treatment for Netherton syndrome; and other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and in other filings the Company has made and may make with the SEC in the future. One should not place undue reliance on these forward-looking statements, which speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as may be required by law.

Media Contact

Kerry Corbit
Kerry@pcgadvisory.com

April 2, 2025 9:00 AM

EDT

•

LOS ANGELES, CA

Exclusive: everle – A New Social Network Quietly Built to Heal the Digital World

In a time when digital platforms permeate every corner of life, meaningful connection has become increasingly rare. Enter everle, the first subscription-based social networking platform designed entirely around genuine connection, mental well-being, and member empowerment — not ad dollars or viral trends.

“While other platforms optimize for engagement, virality, and surveillance-driven monetization, everle is taking a radically different path,” said Tessa Adams, founder of everle. “We’ve been quietly and deliberately building a better way — one that prioritizes depth over dopamine, belonging over broadcasting, and well-being over likes.”

As growing concerns mount over the direction of mainstream digital platforms, recent events highlight the urgency of a new approach. There continues to be a critical gap in today’s digital ecosystem: platforms built for speed, scale, or secrecy — but not for trust, intentionality, or humanity.

everle is not just another social app. It’s a movement to make digital spaces feel human again.

With no ads, no addictive algorithms, and no data harvesting, everle is flipping the script on social networking by putting members — not corporations — in control of their online experience.

The everle team is a group of outside of the confines of Silicon Valley who are tired of the status quo, including NSYNC member Lance Bass, who has been a passionate advocate for mental health and digital wellness. “I believe in everle because it’s exactly what we need right now — a space that’s real, supportive, and rooted in human connection,” said Bass.

The platform is currently rolling out to a growing waitlist of over 100K with invites to those seeking authentic, healthy, and thoughtful online interactions to join the movement.

About everle

everle is the first online social networking platform designed for the everyday human — built around data privacy, mental well-being, and intentional connection. Ad-free, algorithm-free, and powered by a subscription model, everle is redefining what it means to belong in the digital age. Learn more at everle.com.

Media Contact

hello everle
hello@everle.com

April 2, 2025 9:00 AM

EDT

•

WASHINGTON, DC

Actor and Producer Charlie Day to Keynote 2025 OAAA OOH Media Conference as Full Agenda Goes Live

The Out of Home Advertising Association of America (OAAA) today unveiled the full agenda for its 2025 OOH Media Conference, taking place May 5–7 in Boston, with a headlining keynote by actor, writer, and producer, Charlie Day. With powerhouse marketers, agency executives, media analysts, and industry thought leaders set to take the stage, this year’s event promises to be a bold exploration of the expanding role of out of home (OOH) in the modern marketing mix.

Charlie Day, best known for co-creating and starring in It’s Always Sunny in Philadelphia, will bring his signature energy and offbeat perspective to the main stage. In addition to his on-screen success, Day has expanded his creative footprint as an entrepreneur with the launch of Four Walls Whiskey. His keynote will explore how bold storytelling, cultural resonance, and creative risk-taking can drive real-world impact. Underscoring this year’s conference theme, “The Power of Presence,” his session will spotlight how showing up in authentic, unexpected ways can leave a lasting mark on culture and consumers alike.

The 2025 agenda features a who’s-who of brand and media leaders, including:

Kraft Heinz’s North America CMO, Todd Kaplan in a headline session on creativity, culture, and striking the balance between creativity and data, moderated by David Shing
A chief marketing officer roundtable with trailblazing marketers from Bose, New Balance, and CBRE on growth strategies and cutting through the noise
Cracker Barrel’s CMO Sarah Moore on balancing tradition with innovation across social, digital, and loyalty marketing
Generational researcher Jason Dorsey returns to the OOH Media Conference stage unpacking how younger generations think about media, brands, and the workplace
A powerhouse panel of women leaders from Rakuten, Infillion, Gemini, and Intersection on breaking barriers and building brands
Media strategist Brian Wieser on current trends impacting the ad economy and the industry's future, examining shifting dynamics and what these changes mean for how money will flow in a rapidly transforming environment
A candid conversation with the chief executives of the three largest U.S. OOH companies: Clear Channel Outdoor, Lamar Advertising and OUTFRONT Media
A high-impact media investment discussion with senior executives from major agency holding companies on OOH’s growing role in the media mix
Brand leaders from HubSpot, Lesser Evil, and Lalo on how innovative brands are adapting to a rapidly changing media and platform ecosystem, shifting consumer behaviors, and economic complexity
A pharma marketing case study with AstraZeneca on how programmatic DOOH is reshaping patient engagement
LUMA Partners’ Terence Kawaja on how AI, automation, and retail media are redefining the future of OOH

“The 2025 OOH Media Conference showcases the full power and momentum of the out of home industry,” said Anna Bager, President and CEO, OAAA. “This year’s agenda is our most ambitious yet—featuring an inspiring keynote from Charlie Day, plus dynamic conversations with brand leaders, media innovators, and creative visionaries from every major sector. It reflects how far out of home has come and boldly charts where we’re heading next—thriving at the intersection of creativity, technology, commerce, and culture.”

The 2025 OOH Media Conference will also feature deep-dive track sessions and workshops, the 83rd Annual OBIE Awards, the bi-annual OOH Industry Awards, and countless opportunities for networking, inspiration, and industry celebration over three packed days.

To view the full agenda and register for the 2025 OOH Media Conference, visit ooh2025.com/agenda.

About the Out of Home Advertising Association of America (OAAA)

The Out of Home Advertising Association of America (OAAA) is the national trade association for the entire out of home (OOH) advertising industry. OAAA represents over 850 members, including leading media companies, advertisers, agencies, ad-tech providers, and suppliers. OOH media includes billboards, street furniture, transit, place-based media, and digital formats (DOOH) across every sector of the channel. OAAA is the unifying voice for the industry, the authoritative thought leader, and the passionate advocate for advancing OOH advertising in the United States. The legislative unit of OAAA advocates for the responsible growth of OOH with federal, state, and local governments. OAAA-member media companies donate over $500 million annually in public service advertising. Founded in 1891, OAAA is headquartered in Washington, DC, with offices in New York City. For more information, visit https://oaaa.org.

Media Contact

Cassady Nordeen
cassady@purposenorthamerica.com

April 1, 2025 8:59 AM

EDT

•

MADRID, Spain

Kazakhstan’s EA Ventures and Plug and Play Launch €20 Million Fund to Support European Startups

EA Ventures, the venture capital arm of EA Group Holding, has partnered with global innovation platform Plug and Play to launch a €20 million investment fund aimed at accelerating early-stage startups across Europe. Based in Madrid, Spain, the fund is hosted by Plug and Play EMEA Fund Management Company, a regulated entity managing venture initiatives across Europe, the Middle East, and Africa.

The EA Ventures Plug and Play EMEA Fund will focus on seed-stage investments in high-impact technologies, including artificial intelligence, enterprise solutions, fintech, sustainability, mobility, and e-commerce. With ticket sizes ranging from €200,000 to €500,000, the fund aims to back 30–35 promising European startups.

“Spain is entering a new wave of tech entrepreneurship, and we see an opportunity to bring a fresh perspective rooted in global connectivity and agile capital. This partnership enables us to tap into Europe’s deep talent pool while helping founders think and grow beyond borders,” said Yerik Aubakirov, CEO of EA Group Holding.

Officially launched on March 3, 2025, the fund offers portfolio companies access to financial backing, expert mentorship, and Plug and Play’s extensive international network of corporations, investors, and advisors.

“We believe in the immense potential of the Spanish territory and aim to provide both financial and strategic support. Our goal is to connect the best founders with international hubs, enhancing their global reach and agility,” said Seena Amidi, Managing Partner EMEA at Plug and Play Tech Center.

This collaboration brings together Plug and Play’s global acceleration platform with EA Ventures’ dynamic, founder-first investment approach — with the goal of driving innovation and entrepreneurship across Europe.

About EA Ventures and EA Group Holding

EA Ventures, the venture capital arm of EA Group Holding, invests in high-potential startups in the fintech, health tech, blockchain and SaaS sectors. Since 2021, we have focused on seed and pre-Series A companies, offering investments ranging from $500,000 to $2 million. Led by an experienced team of investment professionals and entrepreneurs, the fund leverages our industry expertise to identify and support promising startups, primarily in Europe, with an emphasis on Spain. As part of EA Group Holding, EA Ventures provides portfolio companies with capital, strategic guidance, operational support and access to an international network to help drive sustainable growth and long-term success. For more information, visit eagroup.com.

About Plug and Play

Plug and Play is the leading innovation platform connecting startups, corporations, venture capital firms, universities, and government agencies. Headquartered in Silicon Valley, we operate in 60+ locations across five continents. We offer corporate innovation programs and support our partners through every stage of their innovation journey — from education to execution. We also run startup acceleration programs and manage over $1 billion in assets under management across our funds. Our portfolio includes hundreds of successful companies such as Dropbox, PayPal, Guardant Health, Honey, N26, Rappi, and Turing. For more information, visit https://www.plugandplaytechcenter.com.

Media Contact

Jeanna Skripal
skripal@itcomms.io

March 31, 2025 12:03 PM

EDT

•

TALLINN, Estonia

Motorsport Meets the Future of Finance: CryptoProcessing by CoinsPaid Joins Forces with Eduardo and Fernando Barrichello

CryptoProcessing by CoinsPaid is pleased to announce Eduardo “Dudu” and Fernando “Fefo” Barrichello as official brand ambassadors for 2025. This strategic partnership at the intersection of motorsport and digital finance underscores the shared values of precision, adaptability, and a forward-thinking approach to innovation.

In a sport where every millisecond counts, the unmatched speed and precision of digital finance are becoming more crucial than ever. With Eduardo competing in the FIA World Endurance Championship (WEC) for Racing Spirit of Léman (#10 Aston Martin Vantage AMR GT3 Evo), and Fernando racing in Euroformula Open for Team Motopark (#41 Dallara 324), this partnership brings together the next generation of elite racing talent with the latest evolution of payments.

Max Krupyshev, CEO of CryptoProcessing by CoinsPaid: “Motorsport is about making split-second decisions at over 200 mph. The same goes for digital finance—there’s no time for slow transactions. Technology progresses in cycles—things that once seemed complex become second nature. At one point, electronic fuel injection was a radical innovation in motorsport. Now, it’s essential. The same applies to digital payments. Eduardo and Fernando represent a new generation that understands how innovation shapes the future, and we’re proud to have them on board.”

Barrichellos: Speed, Legacy & Innovation

The Barrichello name is legendary. Their father, Rubens Barrichello, remains one of the most respected figures in Formula 1 history. But Eduardo and Fernando are carving out their own path in the most competitive racing championships on the planet.

Now, they’re not just redefining motorsport—they’re helping drive the future of digital payments.

Eduardo Barrichello: “Racing is all about precision and adaptability, and that’s exactly what Web3 is bringing to the world of finance. CryptoProcessing by CoinsPaid is making digital transactions more intuitive and accessible, and that’s something I’m excited to be part of.”

Fernando Barrichello: “Whether it’s on track or in fintech, the goal is the same: be faster, be more efficient, and always stay ahead of the curve. Partnering with CryptoProcessing by CoinsPaid is like unlocking DRS on the future of finance, its about highlighting how innovation can simplify complex systems, whether in motorsport or global payments.”

A Shared Commitment to Innovation

This partnership is built on a shared vision of progress and adaptability, demonstrating how technology can drive new standards across sectors. CryptoProcessing by CoinsPaid isn’t just another crypto company—it is one of the leaders in digital payments, offering seamless, secure, and efficient solutions that are transforming industries worldwide.

The Future of Racing & Finance Starts Now

Motorsport is built on innovation, and so is Web3. CryptoProcessing by CoinsPaid and the Barrichello brothers are proving that crypto payments aren’t just the future—they’re here, and they’re faster than ever.

The grid is set. The lights are out. 2025 is going full throttle.

About CryproProcessing

CryptoProcessing by CoinsPaid is a trusted provider of cryptocurrency payment solutions for businesses, connecting them with a growing market of over 650 million crypto users worldwide. With over a decade of cryptocurrency expertise, CryptoProcessing serves hundreds of merchants globally across industries, offering seamless integration and support for a wide range of cryptocurrencies to make accepting crypto payments simple and cost-efficient. To learn more, visit https://cryptoprocessing.com.

For important disclaimers, see here.

Media Contact

Nadiia Yakubets
info@coinspaid.com

March 31, 2025 11:32 AM

EDT

•

NEW YORK, NY

This Tape Measure App for Home Renovations Just Got Smarter: Preview Your Room Layout in 3D with Measure Tools – AR Ruler

Anyone who's gone through a renovation knows how chaotic it can get. From endless trips to hardware stores and showrooms to juggling suppliers, contractors, and delivery timelines—it’s a whirlwind of small but crucial decisions. Having an interior designer doesn’t mean you’re off the hook, either. Everyone will be waiting for your decisions and preferences, and one thing is certain: you'll need to measure things—a lot.

Whether you're checking dimensions in a new home, sizing up furniture in a showroom, or imagining how a layout you saw online could fit into your own space, having an accurate measuring tool always at hand is a game-changer.

The Solution: A Tape Measure App That Lives in Your Pocket

With Measure Tools – AR Ruler, you never have to remember to bring a tape measure again. Your phone becomes a smart, augmented reality (AR) ruler you can pull out anytime, anywhere.

Unlike traditional tape measures, which can be awkward (especially on dusty construction sites or in tight spaces), this app lets you measure quickly and comfortably just by pointing your phone’s camera. You don’t need to climb ladders or furniture, crawl into tight spaces, or move heavy items that stand in the way of your measurements.

Measure Tools – AR Ruler is not your average measurement app—it’s a pioneer in the digital measurement space. The camera-based measuring app was launched in 2018 after many years of computer vision experience by the development team at Craftars. Since then, over 900,000 people around the world have used it to measure rooms, preview furniture layouts, calculate distances, and make smarter decisions in construction, real estate, renovation, and interior design.

Whether you're a contractor on a job site, a homeowner redesigning your living room, or an agent showing a property, this AR-powered tool turns your smartphone into a complete space planning assistant.

Key Features

Instant measurements using your phone camera: Quickly measure distances, heights, or object sizes by simply pointing your camera—perfect for on-the-go measurements without needing a physical tape.
3D shapes to preview furniture or objects at true scale: Place realistic, full-scale objects as cubes in your space to see how furniture or appliances will actually fit and feel—before you buy.
Smart modes: lock measurements horizontally or perpendicular to surfaces: Easily measure along the floor or walls with smart axis-locking—great for getting straight lines in cluttered or complex spaces.
Chained measurements to calculate perimeters and areas: Connect multiple points in sequence to measure entire rooms, plan layouts, or calculate floor space and material needs. Works for complex shapes too, not just simple rectangular rooms.
Scan floor layout even when obstacles are in the way: Measure the usable floor area accurately, even if furniture or other objects are blocking the view—no need to move anything around.
Angles: Instantly measure the angle between two segments—useful for checking corners, slopes, or ensuring elements align correctly in your space.

Introducing: Real-Scale 3D Layout Previews

The newest feature in Measure Tools lets you go beyond measuring—now you can preview your entire room layout in 3D.

Instead of guessing whether that beautiful sofa will fit, you can place a virtual object with the exact size of your future purchase directly into your space. This allows you to visualize spacing, flow, and fit before you commit.

While some people try to simulate layouts by placing masking tape or painter’s tape on the floor, this method is time-consuming, messy, and imprecise. You have to measure each side manually, bend down repeatedly to apply tape, and if you want to shift the layout even slightly, you need to remove and redo everything. It leaves sticky residue on the floors and gives you only a flat, 2D outline.

With Measure Tools, you can stand comfortably, place and adjust virtual furniture in seconds, and get a true 3D sense of how the object fits in your space. A few taps replace an hour of crouching and guesswork.

Planning with Pinterest boards or product listings is helpful, but seeing your own space filled in AR is a completely different experience. You’ll immediately spot if something feels too big, too small, or simply wrong for the room. This means fewer mistakes, fewer returns, and less stress.

And if you're ordering custom furniture? Even more reason to be precise. A wrong fit could mean hundreds of dollars lost or weeks of delay for costly adjustments.

Who Can Benefit from the Measure Tools – AR Ruler App

Contractors & Renovation Pros: Speed up site visits, estimate jobs accurately, and avoid rework.
Homeowners & DIYers: Plan your dream space with confidence and avoid expensive mistakes.
Interior Designers: Show clients real-time layout previews and streamline the design process.
Real Estate Agents: Instantly answer buyers’ questions about fit and layout on the spot.

With Measure Tools, you’ll always be ready—equipped with a powerful digital tool that positions you as a true professional, helps you communicate better, and get the job done faster.

Available Now – Try It on Your Next Project

Measure Tools – AR Ruler is available on both mobile platforms: the Android measurement app and the iOS tape measure app both include all the powerful features listed above. Whether you’re measuring a wall, planning a kitchen, or decorating a new apartment, this app helps you work smarter, faster, and more confidently.

Since launch, we’ve been continuously updating, refining, and expanding the app—adding new tools to make measuring easier and more intuitive. Much of this progress is thanks to our growing community. We listen closely to user feedback and actively collaborate with professionals in construction, interior design, and real estate to ensure the app evolves to meet real needs on the ground.

Download today and transform your phone into the smartest measuring tool you own. For support, feedback, or custom feature requests, visit the Measure Tools website.

About Measure Tools

Measure Tools is an advanced measuring tape app that turns your smartphone into a versatile tool for measuring distances, calculating areas, and visualizing spaces. With augmented reality (AR), it functions as a virtual ruler, enabling users to take fast and comfortable room measurements using their phone's camera. Whether you're in real estate, construction, interior design, or simply planning your next home project, Measure Tools makes it easy to measure and map out spaces. With features like chained measurements, angle detection, and 3D object placement, it’s the perfect companion for professionals and DIY enthusiasts alike. For more information, visit https://www.measuretools.net.

Media Contact

George Mincila
hello@measuretools.net

March 31, 2025 9:15 AM

EDT

•

NEW YORK, NY

NextNRG Announces Estimated 139% Year-over-Year Revenue Growth for February 2025

Following the release of its fourth quarter and full-year 2024 financial results, NextNRG, Inc. (NASDAQ: NXXT)—a pioneer in AI-driven energy innovation, transforming how energy is produced, managed, and delivered through its advanced Utility Operating System, smart microgrid technology, wireless EV charging, and on-demand mobile fuel delivery solutions—has reported another month of record performance. The company continues to demonstrate momentum across its smart fueling operations and broader platform of next-generation energy solutions.

In February 2025, NextNRG reported unaudited revenue of approximately $5.09 million, a 139 percent increase over February 2024 and a sequential increase from January, despite fewer operating days. Fuel volumes rose to approximately 1.44 million gallons, up 166 percent year-over-year. The performance marks the second consecutive month of record revenue for the company’s EzFill mobile fueling division.

Recently, NextNRG also reported a 20 percent increase in full-year 2024 revenue to $27.8 million, up from $23.2 million in 2023. Gross profit for the year grew 64 percent to $2.3 million. Fourth quarter revenue rose 21 percent year-over-year to $6.9 million, while gross profit nearly doubled to $652,000. Growth was driven by increased fuel volume, higher-margin delivery operations, and improved pricing discipline.

“We believe our back-to-back record months underscore the power of our growing platform and the momentum we’ve built through strategic expansion. The successful integration of the Shell Oil fleet and our long-term agreement with a global e-commerce leader are now fueling real, measurable growth. As we scale with continued discipline, demand from fleet partners continues to rise, validating our model and vision for the future. With EzFill’s on-demand fueling operating efficiently and NextNRG’s smart energy infrastructure, we are positioned to lead the transformation of how energy is delivered in a connected, AI-driven world,” said Michael D. Farkas, founder and CEO of NextNRG.

As the Company looks ahead to the remainder of 2025, it plans to accelerate its expansion across key verticals including mobile fueling, AI-optimized microgrids, and wireless EV charging. New SaaS contracts and infrastructure deployment initiatives are expected to support recurring revenue growth and long-term scalability.

To find out more about NextNRG, read the latest Q&A here.

A conference call to discuss NextNRG’s full-year 2024 results is scheduled for Monday, March 31, 2025, at 4:30 PM ET.

About NextNRG

NextNRG, Inc. (NASDAQ: NXXT) is Powering What’s Next by implementing artificial intelligence (AI) and machine learning (ML) into renewable energy, next-generation energy infrastructure, battery storage, wireless electric vehicle (EV) charging, and on-demand mobile fuel delivery to create an integrated ecosystem.

At the core of NextNRG’s strategy is its Utility Operating System which leverages AI and ML to help make existing utilities’ energy management as efficient as possible; and the deployment of NextNRG Smart Microgrids, which utilize AI-driven energy management alongside solar power and battery storage to enhance energy efficiency, reduce costs, and improve grid resiliency. These microgrids are designed to serve commercial properties, schools, hospitals, nursing homes, parking garages, rural and tribal lands, recreational facilities, and government properties, expanding energy accessibility while supporting decarbonization initiatives.

NextNRG continues to expand its growing fleet of fuel delivery trucks and national footprint, including the acquisition of Yoshi Mobility’s fuel division and Shell Oil’s trucks, further solidifying its position as a leader in the on-demand fueling industry. NextNRG is also integrating sustainable energy solutions into its mobile fueling operations. The company hopes to be an integral part of assisting its fleet customers in their transition to EV supporting more efficient fuel delivery while advancing clean energy adoption. The transition process is expected to include the deployment of NextNRG’s innovative wireless EV charging solutions.

To find out more visit: www.nextnrg.com.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statement describing NextNRG’s goals, expectations, financial or other projections, intentions, or beliefs is a forward-looking statement and should be considered an at-risk statement. Words such as "expect," "intends," "will," and similar expressions are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including, but not limited to, those related to NextNRG’s business and macroeconomic and geopolitical events. These and other risks are described in NextNRG’s filings with the Securities and Exchange Commission from time to time. NextNRG’s forward-looking statements involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although NextNRG’s forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by NextNRG. Except as required by law, NextNRG undertakes no obligation to update any forward-looking statements for any reason. As a result, you are cautioned not to rely on these forward-looking statements.

Disclaimer

This communication was produced by PRISM MarketView, an affiliate of PCG Advisory Inc., (together "PCG"). PCG is not a registered or licensed broker-dealer nor investment adviser. No information contained in this communication constitutes an offer to sell, a solicitation of an offer to buy, or a recommendation of any security. PCG may be compensated by respective clients for publicizing information relating to its clients’ securities. See www.pcgadvisory.com/disclosures.

Media Contact

PRISM MarketView
info@prismmarketview.com

March 28, 2025 11:10 AM

EDT

•

TALLINN, Estonia

FineVPN Launches New VPN Service Using xRay Protocol for Enhanced Privacy and Security

FineVPN, a leading VPN service provider, is excited to announce the launch of its new VPN service based on the powerful xRay protocol. This innovative addition is designed to enhance user privacy, anonymity, and resistance to blocking, making it an ideal solution for secure internet browsing, streaming, and more.

The xRay protocol, known for its robust traffic encryption and anonymity features, is now available in both Free and Premium packages from FineVPN. The Free plan provides stable and fast connections for basic browsing and streaming without lags, while the Premium plan offers additional features and optimized networks for a superior experience.

Features of FineVPN XRAY

Free Plan:

Resistant to blocking
Traffic encryption
Anonymity
Basic servers stable and fast
Suitable for surfing and streaming without lags
Available countries: France, India, Pakistan, Seychelles

Premium Plan:

All features of the Free Plan
More servers and countries
Optimized networks for improved performance
Ad Filter to block unwanted ads
Accessible with All Time Premium
Available countries: United States, United Kingdom, France, Netherlands, Germany, Ukraine, Russia, United Arab Emirates, Seychelles, Pakistan, India

FineVPN’s xRay-based VPN is designed to meet the growing demand for secure and private internet access, especially in regions where internet restrictions are common. The company aims to provide users with an enhanced internet experience, prioritizing privacy, reliability, and accessibility.

About FineVPN

FineVPN is a reliable VPN service provider offering secure internet connections through a wide range of servers worldwide. With its easy-to-use setup and strong encryption protocols, we deliver a seamless browsing experience for both casual and professional users. For more information, visit https://finevpn.org.

Media Contact

Support Team
support@finevpn.org

March 27, 2025 1:54 PM

EDT

•

CHICAGO, IL

First Class Action Lawsuit Filed Against University of Michigan for Massive Privacy Breach Affecting Thousands of Female Athletes

Stinar Gould Grieco & Hensley, PLLC has filed the first class action lawsuit against the University of Michigan, the Regents of the University of Michigan, Matthew Weiss, and Keffer Development Services, LLC, alleging a massive breach of privacy affecting over 3,300 individuals, primarily female student-athletes.

The lawsuit, filed in the United States District Court for the Eastern District of Michigan (Case No. 2:25-cv-10806), alleges that defendants allowed unauthorized access to sensitive personal information, private photographs, and videos of thousands of student-athletes.

According to the complaint, Matthew Weiss, a former University of Michigan employee, allegedly accessed—without authorization—the social media accounts, emails, cloud storage, and personal information of thousands of female student-athletes over approximately eight years (2015-2023). The complaint alleges that Weiss targeted female athletes and downloaded private photographs and videos that were never intended to be shared beyond the plaintiffs' intimate partners.

"This case represents one of the most significant breaches of student-athlete privacy in recent memory," said Parker Stinar, lead attorney for the plaintiffs.

"Our clients placed their trust in the University of Michigan and its vendors, only to have their most personal and private information compromised due to what we allege was negligence and recklessness."

The lawsuit alleges that the University of Michigan, its Regents, and Keffer Development Services failed to implement adequate security measures, proper supervision, or employee monitoring that would have protected the plaintiffs' privacy.

According to the complaint, Weiss allegedly:

Gained unauthorized access to student-athlete databases maintained by Keffer Development Services
Downloaded personally identifiable information (PII) and medical data of more than 150,000 athletes
Obtained passwords used by athletes to access computer systems
Used this access to download private photographs and videos

The lawsuit includes claims for violations of the Computer Fraud and Abuse Act, the Stored Communications Act, Title IX, and various state laws involving invasion of privacy, negligence, and conversion.

The plaintiffs are seeking damages exceeding $100 million, along with costs, interest, and attorney fees. The class action complaint seeks to represent all persons whose personal information, images, data, social media, or videos were accessed by Weiss without authorization.

"This lawsuit is not only about seeking justice for those whose information was stolen but also about forcing the University of Michigan to confront its systemic failures and ensure such breaches never happen again. The case will hold the institution accountable for its lack of appropriate safeguards and transparency regarding the security of its student-athletes’ personal and medical data.

In the face of such violations, SGGH is committed to turning over every stone in our pursuit of justice. Through litigation, we will uncover the flaws in Michigan’s cyber security protocols that led to this massive breach, and demand real change to protect vulnerable individuals from similar harms in the future.

We will fight relentlessly to secure justice for all those affected." said Parker Stinar, lead attorney for the plaintiffs.

This case highlights the growing concern around data privacy and the security of personal information in the digital age, particularly in university settings where students entrust institutions with their personal data.

About Stinar Gould Grieco & Hensley, PLLC

Stinar Gould Grieco & Hensley, PLLC is a law firm dedicated to protecting the rights of individuals in complex litigation matters. The firm has extensive experience in class action lawsuits, privacy law, and representing victims of institutional failures. Managing Partner, Parker Stinar, previously led the University of Michigan/Robert Anderson sexual abuse matter which resolved for $490 million dollars for more than 1,000 individuals. For more information, visit https://www.sgghlaw.com.

Media Contact

Lynn Smith
lynn@lynnsmithtv.com

March 27, 2025 12:17 PM

EDT

•

LONDON, United Kingdom

ValueTheMarkets Insights: While Big Pharma Stalls, One Small-Cap Breaks Out

ValueTheMarkets, a trusted resource for retail investors offering financial news, in-depth analysis, and investment insights, today shared insights into small-cap biotech stocks.

In a year where the S&P 500 has slipped -1.78% and biotech giants like Novo Nordisk (NYSE: NVO) are under pressure, Medicus Pharma (NASDAQ: MDCX) is breaking away from the pack. The stock has surged 32% year-to-date, outperforming Eli Lilly’s (NYSE: LLY) respectable 9.55% gain and leaving Novo’s -15.9% slide far behind. But it’s not chasing blockbuster weight loss drugs—it’s targeting a radically different frontier: non-invasive skin cancer treatment.

The market's attention remains fixated on obesity drugs, but that trade is looking tired. Novo’s drop reflects valuation fatigue. Lilly’s gains are narrowing. Small-cap biotech moves fast when the story clicks.

Medicus Pharma Ltd (NASDAQ: MDCX) is developing the SkinJect D-MNA patch for basal cell carcinoma (BCC) (1), a proprietary microneedle array that is a non-invasive, painless, and cost-effective alternative to Mohs surgery, the current standard of care. A small, thumb-sized microneedle patch is applied to the skin over the BCC lesion. The patch is painless and easy to administer in a doctor’s office and can be applied during just three weekly 30-minute visits over 2 weeks. This has the potential to provide a simple and affordable solution to BCC patients seeking better treatment options. With over 5 million BCC cases diagnosed annually in the U.S., Medicus Pharma targets a $2 billion share of the $15 billion North American skin cancer market. Its SkinJect patch has projected development costs of $75–$100 million, far below the $648 million industry average (2). Priced at around $1,000, it offers a cost-effective alternative to Mohs surgery ($1,800–$2,500) (3).

Novo Nordisk (NYSE: NVO) just struck a big deal with a Chinese drugmaker, The United Laboratories International Holdings Limited, to license a new weight-loss and diabetes drug, UBT251 (4). The deal could be worth up to $2 billion, with $200 million paid upfront and the rest tied to performance milestones. Novo will also pay royalties if the drug sells well outside of China. United Laboratories retains rights in China, Hong Kong, Macau, and Taiwan, while Novo Nordisk holds exclusive rights elsewhere. Novo Nordisk's new weight-loss drug CagriSema showed 15.7% weight loss in patients with Type 2 diabetes in its most recent trial (5). While effective, the results came in below some analyst expectations, contributing to a negative market reaction.

Eli Lilly (NYSE: LLY) is set to release key results this year from late-stage trials of its experimental weight-loss pill, orforglipron (6). These results are highly anticipated, as the once-daily pill could offer a needle-free option for treating obesity and diabetes. If successful, it may expand access for patients globally and ease supply issues affecting injectable treatments. The pill could also strengthen Eli Lilly’s lead in the fast-growing weight-loss drug market as competitors rush to catch up. Meanwhile, Lilly has recently expanded its cancer drug pipeline by acquiring an experimental PI3K inhibitor from Scorpion Therapeutics (7). This drug, STX-678, targets PI3Ka mutations common in breast, gynecological, and head and neck cancers.

Both Novo and Lilly are now advancing next-generation GLP-1-based therapies, including Novo’s newly licensed UBT251 and Lilly’s injectable retatrutide. Early data from UBT251 show promising double-digit weight loss over a short treatment window, though Lilly’s drug has demonstrated even greater efficacy over longer trials. While Lilly continues to deepen its presence in both obesity and oncology, Novo remains more narrowly focused, with only a limited footprint beyond its core metabolic disease portfolio. The weight-loss space is increasingly defined by heavyweight competition—and fewer fresh angles.

In markets weighed down by macro fatigue and sector rotation, attention gravitates toward headline-grabbing giants, and small caps often get overlooked—until they don’t. While the biggest names fight to meet sky-high expectations, smaller players can deliver outsized returns simply by executing well on underappreciated ideas. These companies don’t need to dominate a $100 billion category to reward investors—they just need to solve a real problem, move quickly, and fly under the radar long enough for the story to catch up to the fundamentals. That’s how some of this year’s most surprising outperformers have pulled well ahead of the S&P 500, which remains down nearly 2% year-to-date. While broader markets churn, select small-cap biotech names are showing that meaningful innovation still gets rewarded. As the weight-loss drug trade gets crowded and priced in, this could be the moment to look beyond the usual suspects.

Discover more about Medicus Pharma and its plans to commercialize its non-invasive SkinJect patch for BCC.

About Digitonic

Digitonic Ltd. is a specialist investor marketing agency dedicated to helping companies reach, engage, and retain investors. From equity crowdfunding to public company investor relations, we support clients at every stage of their capital-raising journey. Our innovative platforms, products, and tools leverage cutting-edge technology to deliver smart, effective investor marketing that drives results. To learn more, visit https://www.digitonic.com.

About ValueTheMarkets

ValueTheMarkets is a trusted resource for retail investors, offering financial news, in-depth analysis, and investment insights. Whether you're exploring stock market trends, researching companies, or seeking strategic insights, our content is designed to keep you informed and engaged. For more information, visit https://www.valuethemarkets.com.

Sources:

Medicus Pharma Investor Presentation, Q1 2025. Accessed February 2025. https://medicuspharma.com/investor-relations/presentations/
National Library of Medicine. Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval. https://pmc.ncbi.nlm.nih.gov/articles/PMC5710275/
Analyst Coverage from Maxim Group, 17 Dec 2024, and Brookline Capital Markets, 23 Dec 2024. Both reports were supplied by Medicus Pharma in February 2025.
(Note: Analyst targets are based on projections and assumptions that may not materialize.)
GlobeNewswire. The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist. March 24, 2025. https://www.globenewswire.com/news-release/2025/03/24/3047656/0/en/The-United-Laboratories-and-Novo-Nordisk-announce-exclusive-license-agreement-for-UBT251-a-GLP-1-GIP-glucagon-triple-receptor-agonist.html
GlobeNewswire. Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial. March 10, 2025. https://www.globenewswire.com/news-release/2025/03/10/3039539/0/en/Novo-Nordisk-A-S-CagriSema-demonstrates-superior-weight-loss-in-adults-with-obesity-or-overweight-and-type-2-diabetes-in-the-REDEFINE-2-trial.html
CNBC. Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer. March 24, 2025. https://www.cnbc.com/2025/03/24/eli-lilly-to-release-weight-loss-pill-orforglipron-trial-data-.html
Lilly. Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program. January 13, 2025. https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-scorpion-therapeutics-mutant-selective-pi3ka

IMPORTANT NOTICE AND DISCLAIMER

PAID ADVERTISEMENT

This communication is a paid advertisement. ValueTheMarkets is a trading name of Digitonic Ltd, and its owners, directors, officers, employees, affiliates, agents and assigns (collectively the “Publisher”) is often paid by one or more of the profiled companies or a third party to disseminate these types of communications. In this case, the Publisher has been compensated by Medicus Pharma to conduct investor awareness advertising and marketing and has paid the Publisher the equivalent of one hundred and seventy five thousand US dollars starting 3rd March 2025 for a period of 4 weeks until 28th March 2025 to produce and disseminate this and other similar articles and certain related banner advertisements. This compensation should be viewed as a major conflict with the Publisher’s ability to provide unbiased information or opinion.

CHANGES IN SHARE TRADING AND PRICE

Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to adversely affect share prices. Frequently companies profiled in our articles experience a large increase in share trading volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in share trading volume and share price may likely occur.

NO OFFER TO SELL OR BUY SECURITIES

This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security.

INFORMATION

Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position.

This communication is based on information generally available to the public and on an interview conducted with the company’s CEO, and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher does not guarantee the accuracy or completeness of the information. Further, the information in this communication is not updated after publication and may become inaccurate or outdated. No reliance should be placed on the price or statistics information and no responsibility or liability is accepted for any error or inaccuracy. Any statements made should not be taken as an endorsement of analyst views.

NO FINANCIAL ADVICE

The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser or a financial adviser. The Publisher has no access to non-public information about publicly traded companies. The information provided is general and impersonal, and is not tailored to any particular individual’s financial situation or investment objective(s) and this communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor or a personal recommendation to deal or invest in any particular company or product. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR+ and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results.

FORWARD LOOKING STATEMENTS

This communication contains forward-looking statements, including statements regarding expected continual growth of the featured companies and/or industry. Statements in this communication that look forward in time, which include everything other than historical information, are based on assumptions and estimates by our content providers and involve risks and uncertainties that may affect the profiled company’s actual results of operations. These statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results and performance to differ materially from any future results or performance expressed or implied in the forward-looking statements. These risks, uncertainties and other factors include, among others: the success of the profiled company’s operations; the size and growth of the market for the company’s products and services; the company’s ability to fund its capital requirements in the near term and long term; pricing pressures; changes in business strategy, practices or customer relationships; general worldwide economic and business conditions; currency exchange and interest rate fluctuations; government, statutory, regulatory or administrative initiatives affecting the company’s business.

INDEMNIFICATION/RELEASE OF LIABILITY

By reading this communication, you acknowledge that you have read and understand this disclaimer in full, and agree and accept that the Publisher provides no warranty in respect of the communication or the profiled company and accepts no liability whatsoever. You acknowledge and accept this disclaimer and that, to the greatest extent permitted under applicable law, you release and hold harmless the Publisher from any and all liability, damages, injury and adverse consequences arising from your use of this communication. You further agree that you are solely responsible for any financial outcome related to or arising from your investment decisions.

TERMS OF USE AND DISCLAIMER

By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here and acknowledge that you have reviewed the Disclaimer found here. If you do not agree to the Terms of Use, please contact valuethemarkets.com to discontinue receiving future communications.

INTELLECTUAL PROPERTY

All trademarks used in this communication are the property of their respective trademark holders. Other than valuethemarkets.com, the Publisher is not affiliated, connected, or associated with, and the communication is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks other than valuethemarkets.com.

AUTHORS: VALUETHEMARKETS

valuethemarkets.com and Digitonic Ltd and our affiliates are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above. This article does not provide any financial advice and is not a recommendation to deal in any securities or product. News and research are not recommendations to deal, and investments may fall in value so that you could lose some or all of your investment. Past performance is not an indicator of future performance.

ValueTheMarkets do not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above piece. ValueTheMarkets have been paid to produce this piece by the company or companies mentioned above. Digitonic Ltd, the owner of valuethemarkets.com, has been paid for the production of this piece by the company or companies mentioned above.

Media Contact

Grant Fraser
editor@valuethemarkets.com

March 27, 2025 12:17 PM

EDT

•

LONDON, United Kingdom

ValueTheMarkets Insights: While Big Pharma Stalls, One Small-Cap Breaks Out

ValueTheMarkets, a trusted resource for retail investors offering financial news, in-depth analysis, and investment insights, today shared insights into small-cap biotech stocks.

In a year where the S&P 500 has slipped -1.78% and biotech giants like Novo Nordisk (NYSE: NVO) are under pressure, Medicus Pharma (NASDAQ: MDCX) is breaking away from the pack. The stock has surged 32% year-to-date, outperforming Eli Lilly’s (NYSE: LLY) respectable 9.55% gain and leaving Novo’s -15.9% slide far behind. But it’s not chasing blockbuster weight loss drugs—it’s targeting a radically different frontier: non-invasive skin cancer treatment.

The market's attention remains fixated on obesity drugs, but that trade is looking tired. Novo’s drop reflects valuation fatigue. Lilly’s gains are narrowing. Small-cap biotech moves fast when the story clicks.

Medicus Pharma Ltd (NASDAQ: MDCX) is developing the SkinJect D-MNA patch for basal cell carcinoma (BCC) (1), a proprietary microneedle array that is a non-invasive, painless, and cost-effective alternative to Mohs surgery, the current standard of care. A small, thumb-sized microneedle patch is applied to the skin over the BCC lesion. The patch is painless and easy to administer in a doctor’s office and can be applied during just three weekly 30-minute visits over 2 weeks. This has the potential to provide a simple and affordable solution to BCC patients seeking better treatment options. With over 5 million BCC cases diagnosed annually in the U.S., Medicus Pharma targets a $2 billion share of the $15 billion North American skin cancer market. Its SkinJect patch has projected development costs of $75–$100 million, far below the $648 million industry average (2). Priced at around $1,000, it offers a cost-effective alternative to Mohs surgery ($1,800–$2,500) (3).

Novo Nordisk (NYSE: NVO) just struck a big deal with a Chinese drugmaker, The United Laboratories International Holdings Limited, to license a new weight-loss and diabetes drug, UBT251 (4). The deal could be worth up to $2 billion, with $200 million paid upfront and the rest tied to performance milestones. Novo will also pay royalties if the drug sells well outside of China. United Laboratories retains rights in China, Hong Kong, Macau, and Taiwan, while Novo Nordisk holds exclusive rights elsewhere. Novo Nordisk's new weight-loss drug CagriSema showed 15.7% weight loss in patients with Type 2 diabetes in its most recent trial (5). While effective, the results came in below some analyst expectations, contributing to a negative market reaction.

Eli Lilly (NYSE: LLY) is set to release key results this year from late-stage trials of its experimental weight-loss pill, orforglipron (6). These results are highly anticipated, as the once-daily pill could offer a needle-free option for treating obesity and diabetes. If successful, it may expand access for patients globally and ease supply issues affecting injectable treatments. The pill could also strengthen Eli Lilly’s lead in the fast-growing weight-loss drug market as competitors rush to catch up. Meanwhile, Lilly has recently expanded its cancer drug pipeline by acquiring an experimental PI3K inhibitor from Scorpion Therapeutics (7). This drug, STX-678, targets PI3Ka mutations common in breast, gynecological, and head and neck cancers.

Both Novo and Lilly are now advancing next-generation GLP-1-based therapies, including Novo’s newly licensed UBT251 and Lilly’s injectable retatrutide. Early data from UBT251 show promising double-digit weight loss over a short treatment window, though Lilly’s drug has demonstrated even greater efficacy over longer trials. While Lilly continues to deepen its presence in both obesity and oncology, Novo remains more narrowly focused, with only a limited footprint beyond its core metabolic disease portfolio. The weight-loss space is increasingly defined by heavyweight competition—and fewer fresh angles.

In markets weighed down by macro fatigue and sector rotation, attention gravitates toward headline-grabbing giants, and small caps often get overlooked—until they don’t. While the biggest names fight to meet sky-high expectations, smaller players can deliver outsized returns simply by executing well on underappreciated ideas. These companies don’t need to dominate a $100 billion category to reward investors—they just need to solve a real problem, move quickly, and fly under the radar long enough for the story to catch up to the fundamentals. That’s how some of this year’s most surprising outperformers have pulled well ahead of the S&P 500, which remains down nearly 2% year-to-date. While broader markets churn, select small-cap biotech names are showing that meaningful innovation still gets rewarded. As the weight-loss drug trade gets crowded and priced in, this could be the moment to look beyond the usual suspects.

Discover more about Medicus Pharma and its plans to commercialize its non-invasive SkinJect patch for BCC.

About Digitonic

Digitonic Ltd. is a specialist investor marketing agency dedicated to helping companies reach, engage, and retain investors. From equity crowdfunding to public company investor relations, we support clients at every stage of their capital-raising journey. Our innovative platforms, products, and tools leverage cutting-edge technology to deliver smart, effective investor marketing that drives results. To learn more, visit https://www.digitonic.com.

About ValueTheMarkets

ValueTheMarkets is a trusted resource for retail investors, offering financial news, in-depth analysis, and investment insights. Whether you're exploring stock market trends, researching companies, or seeking strategic insights, our content is designed to keep you informed and engaged. For more information, visit https://www.valuethemarkets.com.

Sources:

Medicus Pharma Investor Presentation, Q1 2025. Accessed February 2025. https://medicuspharma.com/investor-relations/presentations/
National Library of Medicine. Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval. https://pmc.ncbi.nlm.nih.gov/articles/PMC5710275/
Analyst Coverage from Maxim Group, 17 Dec 2024, and Brookline Capital Markets, 23 Dec 2024. Both reports were supplied by Medicus Pharma in February 2025.
(Note: Analyst targets are based on projections and assumptions that may not materialize.)
GlobeNewswire. The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist. March 24, 2025. https://www.globenewswire.com/news-release/2025/03/24/3047656/0/en/The-United-Laboratories-and-Novo-Nordisk-announce-exclusive-license-agreement-for-UBT251-a-GLP-1-GIP-glucagon-triple-receptor-agonist.html
GlobeNewswire. Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial. March 10, 2025. https://www.globenewswire.com/news-release/2025/03/10/3039539/0/en/Novo-Nordisk-A-S-CagriSema-demonstrates-superior-weight-loss-in-adults-with-obesity-or-overweight-and-type-2-diabetes-in-the-REDEFINE-2-trial.html
CNBC. Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer. March 24, 2025. https://www.cnbc.com/2025/03/24/eli-lilly-to-release-weight-loss-pill-orforglipron-trial-data-.html
Lilly. Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program. January 13, 2025. https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-scorpion-therapeutics-mutant-selective-pi3ka

IMPORTANT NOTICE AND DISCLAIMER

PAID ADVERTISEMENT

This communication is a paid advertisement. ValueTheMarkets is a trading name of Digitonic Ltd, and its owners, directors, officers, employees, affiliates, agents and assigns (collectively the “Publisher”) is often paid by one or more of the profiled companies or a third party to disseminate these types of communications. In this case, the Publisher has been compensated by Medicus Pharma to conduct investor awareness advertising and marketing and has paid the Publisher the equivalent of one hundred and seventy five thousand US dollars starting 3rd March 2025 for a period of 4 weeks until 28th March 2025 to produce and disseminate this and other similar articles and certain related banner advertisements. This compensation should be viewed as a major conflict with the Publisher’s ability to provide unbiased information or opinion.

CHANGES IN SHARE TRADING AND PRICE

Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to adversely affect share prices. Frequently companies profiled in our articles experience a large increase in share trading volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in share trading volume and share price may likely occur.

NO OFFER TO SELL OR BUY SECURITIES

This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security.

INFORMATION

Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position.

This communication is based on information generally available to the public and on an interview conducted with the company’s CEO, and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher does not guarantee the accuracy or completeness of the information. Further, the information in this communication is not updated after publication and may become inaccurate or outdated. No reliance should be placed on the price or statistics information and no responsibility or liability is accepted for any error or inaccuracy. Any statements made should not be taken as an endorsement of analyst views.

NO FINANCIAL ADVICE

The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser or a financial adviser. The Publisher has no access to non-public information about publicly traded companies. The information provided is general and impersonal, and is not tailored to any particular individual’s financial situation or investment objective(s) and this communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor or a personal recommendation to deal or invest in any particular company or product. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR+ and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results.

FORWARD LOOKING STATEMENTS

This communication contains forward-looking statements, including statements regarding expected continual growth of the featured companies and/or industry. Statements in this communication that look forward in time, which include everything other than historical information, are based on assumptions and estimates by our content providers and involve risks and uncertainties that may affect the profiled company’s actual results of operations. These statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results and performance to differ materially from any future results or performance expressed or implied in the forward-looking statements. These risks, uncertainties and other factors include, among others: the success of the profiled company’s operations; the size and growth of the market for the company’s products and services; the company’s ability to fund its capital requirements in the near term and long term; pricing pressures; changes in business strategy, practices or customer relationships; general worldwide economic and business conditions; currency exchange and interest rate fluctuations; government, statutory, regulatory or administrative initiatives affecting the company’s business.

INDEMNIFICATION/RELEASE OF LIABILITY

By reading this communication, you acknowledge that you have read and understand this disclaimer in full, and agree and accept that the Publisher provides no warranty in respect of the communication or the profiled company and accepts no liability whatsoever. You acknowledge and accept this disclaimer and that, to the greatest extent permitted under applicable law, you release and hold harmless the Publisher from any and all liability, damages, injury and adverse consequences arising from your use of this communication. You further agree that you are solely responsible for any financial outcome related to or arising from your investment decisions.

TERMS OF USE AND DISCLAIMER

By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here and acknowledge that you have reviewed the Disclaimer found here. If you do not agree to the Terms of Use, please contact valuethemarkets.com to discontinue receiving future communications.

INTELLECTUAL PROPERTY

All trademarks used in this communication are the property of their respective trademark holders. Other than valuethemarkets.com, the Publisher is not affiliated, connected, or associated with, and the communication is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks other than valuethemarkets.com.

AUTHORS: VALUETHEMARKETS

valuethemarkets.com and Digitonic Ltd and our affiliates are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above. This article does not provide any financial advice and is not a recommendation to deal in any securities or product. News and research are not recommendations to deal, and investments may fall in value so that you could lose some or all of your investment. Past performance is not an indicator of future performance.

ValueTheMarkets do not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above piece. ValueTheMarkets have been paid to produce this piece by the company or companies mentioned above. Digitonic Ltd, the owner of valuethemarkets.com, has been paid for the production of this piece by the company or companies mentioned above.

March 27, 2025 12:06 PM

EDT

•

LONDON, United Kingdom

ValueTheMarkets Insights: Healthcare Climbs as Tech Stumbles in 2025 Shift

ValueTheMarkets, a trusted resource for retail investors offering financial news, in-depth analysis, and investment insights, today shared insights into the divergence in performance between the tech and healthcare sectors.

Year-to-date, the S&P 500 Information Technology Index has dropped -7.56%, signaling a pause in the multi-year rally that carried names like Broadcom Inc (NASDAQ: AVGO) and ServiceNow Inc (NYSE: NOW) to new highs. These long-time favorites delivered consistent gains over the past five years, but 2025 has brought a shift. Meanwhile, the S&P 500 Health Care Index has climbed 6.04%, supported by renewed interest in biotech and other speculative segments. Investors appear to be rotating into sectors with perceived upside from innovation and pipeline potential, even as traditional tech leaders face profit-taking and valuation concerns. One early standout in this rotation is Medicus Pharma (NASDAQ: MDCX), which has gained 32.1% year-to-date. This momentum reflects a growing appetite for small-cap names with promising clinical assets and strong catalysts in the quarters ahead.

This divergence between tech and healthcare highlights a broader market reassessment of risk and growth. Investors who once chased margin expansion and cloud-driven revenue in tech are now eyeing the asymmetric upside in clinical-stage biotech and emerging healthcare platforms. While tech giants grapple with elevated expectations and compressed multiples, health care offers a different kind of narrative—one centered on breakthrough therapies, regulatory milestones, and long-term demographic demand. The capital rotation suggests that risk-on sentiment hasn't disappeared; it's just finding new avenues where innovation feels underpriced and progress is more tangible.

Medicus Pharma Ltd. (NASDAQ: MDCX) is one little-known micro-cap making strides with its innovative SkinJect microneedle patch for basal cell carcinoma (BCC) (1). Currently in Phase 2 trials and already showing promising interim results (2), the SkinJect patch offers patients a painless, cost-effective alternative to invasive Mohs surgery. The treatment targets a lucrative $7B market and is on track to potentially secure FDA Fast-Track designation within months. Medicus aims to grow its pipeline through acquisitions and partnerships to deliver innovative products with strong commercial potential. The company has no long-term debt and a deep commitment to treat shareholders equally.

Broadcom Inc’s (NASDAQ: AVGO) nearly 19% stock decline year-to-date reflects a mix of industry pressure and company-specific concerns. The broader tech sector has come under strain as recession fears and shifting U.S. policy drive a pullback in high-growth names. Investors have also grown cautious about Broadcom’s AI position amid rising competition from low-cost model developers like DeepSeek, which could reduce demand for its high-end chips. Manufacturing concerns have surfaced as Broadcom reportedly tests Intel’s production, raising doubts given Intel’s output issues. These headwinds have overshadowed strong Q1 results (3), with 25% revenue growth and solid AI-related gains. In March, Broadcom disclosed four major VMware security flaws. Three were actively exploited zero-days; another allowed low-level users to gain elevated access on virtual machines (4). These incidents have sparked concerns about ongoing cybersecurity risks tied to VMware, a key part of Broadcom’s enterprise software portfolio.

ServiceNow Inc (NYSE: NOW) has faced several headwinds this year that have put downward pressure on its stock. The company reported softer-than-expected subscription revenue growth for 2025 (5), which was influenced by negative currency exchange rates and a slower revenue recognition tied to its shift toward a consumption-based pricing model for its new AI products. In addition, its federal business remains concentrated towards the end of the year, which affects the timing of revenue recognition and contributes to the guidance coming in below analyst consensus. These factors have dampened investor sentiment, with the stock declining nearly 19% year-to-date despite underlying business strengths.

The contrasting trajectories between tech and health care underscore a broader market rotation, with investors seeking growth in areas less exposed to cyclical headwinds and more aligned with innovation-driven upside. While once-reliable names like Broadcom and ServiceNow contend with shifting business dynamics and valuation resets, emerging players in health care are capturing attention with disruptive platforms and near-term catalysts. As capital flows follow conviction, the spotlight appears to be shifting toward companies offering clinical innovation, operational discipline, and strategic agility in a changing market landscape.

The biotech industry thrives on innovation, and some companies stand out for their unique approach to treating high-demand conditions.

For more information in emerging biotech developments, visit here.

About Digitonic

Digitonic Ltd. is a specialist investor marketing agency dedicated to helping companies reach, engage, and retain investors. From equity crowdfunding to public company investor relations, we support clients at every stage of their capital-raising journey. Our innovative platforms, products, and tools leverage cutting-edge technology to deliver smart, effective investor marketing that drives results. To learn more, visit https://www.digitonic.com.

About ValueTheMarkets

ValueTheMarkets is a trusted resource for retail investors, offering financial news, in-depth analysis, and investment insights. Whether you're exploring stock market trends, researching companies, or seeking strategic insights, our content is designed to keep you informed and engaged. For more information, visit https://www.valuethemarkets.com.

Sources:

Medicus Pharma Investor Presentation, Q1 2025. Accessed February 2025. https://medicuspharma.com/investor-relations/presentations/
ValueTheMarkets. Medicus Pharma Ltd Announces Positively Trending Interim Analysis For Sknjct-003 Phase 2 Clinical Study To Non-Invasively Treat Basal Cell Carcinoma Of The Skin (Bcc). March 06, 2025. https://www.valuethemarkets.com/news/press-releases/medicus-pharma-ltd-announces-positively-trending-interim-analysis-for-phase-2-clinical-study
PR Newswire. Broadcom Inc. Announces First Quarter Fiscal Year 2025 Financial Results and Quarterly Dividend. March 6, 2025. https://www.prnewswire.com/news-releases/broadcom-inc-announces-first-quarter-fiscal-year-2025-financial-results-and-quarterly-dividend-302395106.html
The Hacker News. New Security Flaws Found in VMware Tools and CrushFTP — High Risk, No Workaround. March 26, 2025. https://thehackernews.com/2025/03/new-security-flaws-found-in-vmware.html
ServiceNow. ServiceNow Reports Fourth Quarter and Full-Year 2024 Financial Results. January 29, 2025. https://www.servicenow.com/company/media/press-room/fourth-quarter-full-year-2024-financial-results.html

IMPORTANT NOTICE AND DISCLAIMER

PAID ADVERTISEMENT

This communication is a paid advertisement. ValueTheMarkets is a trading name of Digitonic Ltd, and its owners, directors, officers, employees, affiliates, agents and assigns (collectively the “Publisher”) is often paid by one or more of the profiled companies or a third party to disseminate these types of communications. In this case, the Publisher has been compensated by Medicus Pharma to conduct investor awareness advertising and marketing and has paid the Publisher the equivalent of one hundred and seventy five thousand US dollars starting 3rd March 2025 for a period of 4 weeks until 28th March 2025 to produce and disseminate this and other similar articles and certain related banner advertisements. This compensation should be viewed as a major conflict with the Publisher’s ability to provide unbiased information or opinion.

CHANGES IN SHARE TRADING AND PRICE

Readers should beware that third parties, profiled companies, and/or their affiliates may liquidate shares of the profiled companies at any time, including at or near the time you receive this communication, which has the potential to adversely affect share prices. Frequently companies profiled in our articles experience a large increase in share trading volume and share price during the course of investor awareness marketing, which often ends as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in share trading volume and share price may likely occur.

NO OFFER TO SELL OR BUY SECURITIES

This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security.

INFORMATION

Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position.

This communication is based on information generally available to the public and on an interview conducted with the company’s CEO, and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher does not guarantee the accuracy or completeness of the information. Further, the information in this communication is not updated after publication and may become inaccurate or outdated. No reliance should be placed on the price or statistics information and no responsibility or liability is accepted for any error or inaccuracy. Any statements made should not be taken as an endorsement of analyst views.

NO FINANCIAL ADVICE

The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser or a financial adviser. The Publisher has no access to non-public information about publicly traded companies. The information provided is general and impersonal, and is not tailored to any particular individual’s financial situation or investment objective(s) and this communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor or a personal recommendation to deal or invest in any particular company or product. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR+ and/or other government filings. Investing in securities, particularly microcap securities, is speculative and carries a high degree of risk. Past performance does not guarantee future results.

FORWARD LOOKING STATEMENTS

This communication contains forward-looking statements, including statements regarding expected continual growth of the featured companies and/or industry. Statements in this communication that look forward in time, which include everything other than historical information, are based on assumptions and estimates by our content providers and involve risks and uncertainties that may affect the profiled company’s actual results of operations. These statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results and performance to differ materially from any future results or performance expressed or implied in the forward-looking statements. These risks, uncertainties and other factors include, among others: the success of the profiled company’s operations; the size and growth of the market for the company’s products and services; the company’s ability to fund its capital requirements in the near term and long term; pricing pressures; changes in business strategy, practices or customer relationships; general worldwide economic and business conditions; currency exchange and interest rate fluctuations; government, statutory, regulatory or administrative initiatives affecting the company’s business.

INDEMNIFICATION/RELEASE OF LIABILITY

By reading this communication, you acknowledge that you have read and understand this disclaimer in full, and agree and accept that the Publisher provides no warranty in respect of the communication or the profiled company and accepts no liability whatsoever. You acknowledge and accept this disclaimer and that, to the greatest extent permitted under applicable law, you release and hold harmless the Publisher from any and all liability, damages, injury and adverse consequences arising from your use of this communication. You further agree that you are solely responsible for any financial outcome related to or arising from your investment decisions.

TERMS OF USE AND DISCLAIMER

By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here and acknowledge that you have reviewed the Disclaimer found here. If you do not agree to the Terms of Use, please contact valuethemarkets.com to discontinue receiving future communications.

INTELLECTUAL PROPERTY

All trademarks used in this communication are the property of their respective trademark holders. Other than valuethemarkets.com, the Publisher is not affiliated, connected, or associated with, and the communication is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks other than valuethemarkets.com.

AUTHORS: VALUETHEMARKETS

valuethemarkets.com and Digitonic Ltd and our affiliates are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above. This article does not provide any financial advice and is not a recommendation to deal in any securities or product. News and research are not recommendations to deal, and investments may fall in value so that you could lose some or all of your investment. Past performance is not an indicator of future performance.

ValueTheMarkets do not hold any position in the stock(s) and/or financial instrument(s) mentioned in the above piece. ValueTheMarkets have been paid to produce this piece by the company or companies mentioned above. Digitonic Ltd, the owner of valuethemarkets.com, has been paid for the production of this piece by the company or companies mentioned above.

Media Contact

Grant Fraser
editor@valuethemarkets.com

March 27, 2025 11:47 AM

EDT

•

MIAMI, FL

Miami AI Agent Summit Opens Registration, Hosted by Miami AI Hub and CrewAI

Miami will take center stage in the global artificial intelligence conversation on April 5, 2025 as it hosts the Miami AI Agent Summit, presented by Miami AI Hub and CrewAI. This high-impact, half-day event will explore the accelerating role of autonomous AI agents in transforming industries, streamlining operations, and reshaping how businesses and societies function. Miami AI Agent Summit is part of CrewAI Enterprise AI Agent Week, a global celebration of AI agent innovation happening in cities worldwide, and will take place at the innovation campus and startup hub The Lab Miami.

Miami AI Agent Summit is designed for builders, founders, enterprise leaders, investors, and researchers. Over 200 attendees will gather for an afternoon of meaningful dialogue, visionary thinking, and practical insights into one of AI’s most transformative domains. Discussions will center on how intelligent agents are deployed in real-world environments, automating workflows, making complex decisions, and augmenting human capabilities.

Opening remarks will be delivered by João (Joe) Moura, founder and CEO of CrewAI, a leader in enterprise AI agent orchestration, and Burhan Sebin, founder of Miami AI Hub. Burhan Sebin is a leading force in Miami’s AI landscape, committed to making the city a global hub for responsible and accessible AI development. Through his work building Miami AI Hub, he has helped bring together startups, corporate partners, and technologists in a collaborative space designed to unlock AI’s potential across disciplines and industries. He is working to establish strong AI ecosystem linkages between the United States, Southern Europe, and Latin America.

The event will open with a Powerhouse Fireside Chat featuring forward thinkers Clem Delangue, co-founder and CEO of Hugging Face, a global pioneer in open-source AI and collaborative machine learning, and Greg Isenberg, founder and CEO of Late Checkout, a builder of digital communities and product strategy at the intersection of technology and culture.

Additional speakers from Microsoft, Amazon Web Services, boldstartVC, J.P. Morgan, and leading AI startups will join throughout the afternoon. Programming will include expert panels on enterprise implementation and startup innovation within the AI agent ecosystem.

This gathering marks a milestone for Miami’s emergence as a serious player in global AI. The summit offers participants a rare opportunity to engage directly with the field's top minds, discover new AI agent products, and connect with Miami’s fast-growing tech and innovation community.

Miami AI Agent Summit will take place on April 5, 2025, from 12:00 p.m. to 5:00 p.m. at The Lab Miami. Registration will open soon, and space is limited. Please apply here: https://lu.ma/68ozqs92

About Miami AI Hub

Miami AI Hub drives innovation and collaboration in artificial intelligence within the city’s dynamic tech ecosystem. Founded by Burhan Sebin, a recognized AI leader, the hub connects Miami to the global AI landscape, bridging the U.S., Italy, Spain, and Latin America. Sebin previously led research and entrepreneurship at Venture Miami, shaping policies to support the city’s tech growth.

With over 4,000 participants, 50+ AI startup showcases, and speakers from industry leaders like NVIDIA, Apple, Google, and AWS, Miami AI Hub serves as an innovation catalyst, community hub, and startup launchpad. It advances AI-driven solutions, fosters collaboration, and provides cutting-edge education and mentorship to empower the next generation of AI pioneers.

For more information, visit www.miamiaihub.com.

Media Contact

Cigdem Oztabak
cigdem@pirix.co

March 27, 2025 11:15 AM

EDT

•

BEIJING, China

Hu Di, Business President of 58.com (Group), Named One of the 2025 Forbes China "20 Women to Watch in Business"

On March 11, Forbes China and Sports Illustrated co-hosted the 2025 Forbes China Women's Summit at Bund One in Shanghai. The summit presented a global perspective on contemporary Chinese women in diverse fields, bringing together outstanding women from various industries to explore how female leadership can shape a better future.

During the summit, Forbes China released the 2025 "20 Women to Watch in Business" list, showcasing female entrepreneurs who have demonstrated resilience in adversity. By highlighting their extraordinary courage and wisdom, the list aims to inspire more women to take center stage, bring new vitality to the business world, and become an indispensable force in shaping the future. Hu Di, Business President of 58.com (Group), was recognized as one of the 2025 Forbes China "20 Women to Watch in Business."

The honorees came from a range of industries and niche sectors, including semiconductors, healthcare, and software & IT services. Notably, the semiconductor industry accounts for the largest share at 20%, while an impressive 35% of the listed individuals are involved in artificial intelligence. These figures indicate a significant rise in the number of women venturing into deep-tech entrepreneurship.

As the youngest Business President of 58.com (Group), Hu Di has progressed from a university recruit to a core member of the entrepreneurial team within an internet company. Over the past 12 years, she has remained deeply engaged in the digital media sector, achieving remarkable success in advancing high-quality employment, platform ecosystem development, technological innovation, user value enhancement, and exporting China’s life service expertise to international markets.

A pioneering entrepreneur of the post-’90s generation, Hu Di graduated from Peking University’s Guanghua School of Management and was a visiting scholar in innovation at Yale University. She currently serves as Vice President of the Capital Internet Association, a member of the 7th Committee of the Chaoyang District Youth Federation in Beijing, a deputy to the 17th and 18th People's Congress of Tianjin, Vice President of the Beijing Youth New Media Association, a member of the Tianjin Business Environment Expert Committee, an executive director of the China Youth New Media Association, and a judge for the Greater China Effie Awards and Golden Investment Awards.

Since joining 58.com in July 2012, she has risen to her current role as Business President of 58.com Group. She has received numerous accolades, including 2023 Beijing Employment and Entrepreneurship Outstanding Individual, 2024 Beijing Role Model – Most Outstanding Internet Professional, and 2024 Hurun U35 China Entrepreneurship Pioneer.

Content sourced from Forbes China.

About 58.com

58.com is a leading lifestyle services platform in China that operates across a broad range of sectors including recruitment, real estate, automotive, and local lifestyle services. For more information, please visit https://bj.58.com.

Media Contact

Shengxiang Wang
wangshengxiang01@58.com

March 26, 2025 9:41 PM

EDT

•

ALPHARETTA, GA

Michael VanPatten’s “Roswell Flying Crane over the Waterfalls” Selected for Prestigious Art of Georgia Exhibit

Artist, technologist, and entrepreneur Michael VanPatten has announced that his wildlife photography piece, Roswell Flying Crane Over the Waterfalls, has been selected for display in the upcoming Art of Georgia exhibit. The piece will be showcased at either the State Capitol or the Governor’s Mansion, where it will remain on view as part of the exhibition running from January 2025 through December 2026.

VanPatten’s work was chosen through the Art of Georgia contest, organized by the Georgia Council for the Arts, which highlights artwork showcasing the state’s landscapes and natural beauty. His winning piece is one of 47 selected for the exhibition, following a review process that involved the governor and his staff evaluating numerous submissions.

Roswell Flying Crane Over the Waterfalls is a striking composition capturing a blue heron in mid-flight above a cascading waterfall in Roswell, Georgia. The image balances movement and serenity, with the heron’s outstretched wings mirroring the graceful flow of water beneath it. The scene evokes a sense of freedom and tranquility, drawing viewers into a moment of stillness.

“It’s truly an honor to have my work recognized. Having my piece selected by the governor and displayed in such a prominent setting is an unexpected and humbling achievement,” VanPatten said. “I don’t usually enter competitions, but I saw this as an opportunity to share my perspective on Georgia’s beauty.”

VanPatten has spent years capturing landscapes, wildlife, and cityscapes, developing a unique eye for composition. After a career in technology, finance, and marketing, he returned to art full time, blending traditional photography with AI-driven enhancements to create images that challenge perception and engage viewers in new ways. His work explores surrealism, depth, and movement, utilizing digital tools to refine and elevate his original photographs.

VanPatten aims to continue breaking artistic barriers and invites viewers to experience his work with an immersive lens as Roswell Flying Crane Over the Waterfalls prepares for its unveiling.

About Michael VanPatten

Michael VanPatten is an artist, technologist, and entrepreneur blending photography with digital artistry. After a career in tech, marketing, and finance, he founded View Finder Arts, capturing stunning landscapes, seascapes, and cityscapes using cameras, drones, and AI-driven enhancements. His limited-edition works are featured in offices, galleries, and private collections.

Explore his work or inquire about purchases at https://viewfinderarts.com.

Media Contact

Michael VanPatten
michael@viewfinderarts.com

March 26, 2025 9:23 PM

EDT

•

NEW YORK, NY

Omni, the First Crypto Wallet to Pioneer the Multi-Chain Web3 Experience, Acquired by Echo Base Holdings

Omni Acquisition Corp. ("OAC"), an affiliate of Echo Base Holdings ("Echo Base"), acquired the assets, operations, and key staff of the Omni Wallet ("Omni"), a leading Web3 wallet known for pioneering multi-chain integration, from Omni Ltd. This Echo Base acquisition further extends the ecosystem of cryptocurrency and fintech-based ventures to give users full crypto autonomy across more than 25 blockchain networks. The Echo base portfolio includes Paxful, the world’s largest people-powered marketplace, connecting over 14 million users across 140+ countries to move, earn, save, and store money - even without a bank account.

Omni is the most comprehensive wallet in Web3, aggregating the in-demand features, such as swapping, staking, lending, token management, DeFi, NFTs, and more into one mobile-first platform. Omni's multi-chain support and full-suite product integrations aim to make any crypto function as user-friendly as ordering an Uber. Omni's key employees joining the global Echo Base team will continue building on the platform and scale further user adoption while shipping new cutting-edge products.

In 2021, Omni launched as the next generation Web3 super app, redefining crypto accessibility by seamlessly integrating assets, staking, NFTs, and dApps across 25+ blockchains—including EVM, non-EVM, and major Layer 2 solutions. Omni addressed the increasing complexity of managing diverse blockchain assets, introducing groundbreaking ease with its intuitive Explore Screen, allowing users to effortlessly stake, swap, and bridge tokens, engage in liquid staking without lockups, and directly access dApps like Yearn Finance and Aave V3. It consolidated multiple wallet management into one streamlined experience by enabling seamless import of wallets like Metamask, Phantom, and Keplr. Omni further enhanced convenience with a native fiat on-ramp. Its robust security featured direct Ledger hardware wallet integration, ensuring assets remain protected. Omni unified NFTs across Ethereum, Polygon, Solana, and beyond, showcasing them within one elegant multi-chain gallery. Built from first principles to tackle Web3's evolving demands, Omni simplified complex interactions, making Web3 universally accessible.

Founded by co-founders and core team members, Apurv Mishra, Philip Zudemberg, and Serafin Lion Engel, are excited for the new chapter ahead for Omni—continuing to deliver unmatched functionality, security, and always staying ahead to make crypto accessible.

"From the beginning, our goal at Omni has been to simplify digital portfolio management and give users access to all of web3 in one approachable, effective, and engaging app," says Serafin Lion Engel, CEO of Omni and StakeKit. "Joining the Echo Base ecosystem will supercharge Omni's growth trajectory as the home for all things staking and DeFi. We're excited to see Omni reach new heights with the Echo Base team."

"The Echo Base portfolio provides an exceptional trading experience for our crypto users from on-ramp to arbitrage to yield generation. Bringing Omni into our ecosystem equips our users with best-in-class storage and utility solutions for their assets. Now users can manage all their digital finance needs without leaving our portfolio of products," adds Roshan Dharia, CEO of Echo Base.

About StakeKit

StakeKit provides the most comprehensive infrastructure for accessing, orchestrating, and monetizing staking and DeFi yields across Web3. Trusted by industry leaders such as Ledger, Zerion, and Tangem, currently powering more than 1,000 yields across more than 75 blockchain networks, spanning staking, liquid staking, restaking, Real-World Assets (RWAs), and DeFi. To learn more, visit www.stakek.it.

About Omni

Launched in 2021, Omni is a comprehensive Web3 wallet supporting assets across 25+ blockchain networks, enabling seamless token management, DeFi activity, NFTs, and multi-chain staking with a single mnemonic. It aggregates bridging and DEX services for efficient swaps, abstracts staking complexity, integrates Ledger for security, and offers WalletConnect, fiat on-ramp, and broad NFT support. For more information, visit www.omni.app.

Media Contact

Apurv Mishra
apurv@stakek.it

March 26, 2025 11:40 AM

EDT

•

TALLINN, Estonia

Wallester Celebrates Record Growth in 2024

Wallester, the Estonian-based digital finance leader specialising in innovative digital financial solutions and card issuance, announced the conclusion of a transformative year marked by unprecedented growth and strategic market expansion across Europe, reflecting the growing demand for innovative payment solutions in the FinTech sector.

Robust Financial Performance

Financially, the firm demonstrated impressive performance. Unaudited revenue for the year reached €17.2M, representing an 87% Year-over-Year (YoY) increase. These figures underscore the company’s robust financial health and operational efficiency.

Under the leadership of CEO and co-founder Sergei Astafjev, the organisation achieved exceptional growth across its business segments. Specifically, unaudited revenue reached €17.2M, marking an 87% YoY increase. Within this, Wallester White-Label revenue grew to €8.5M, a 70% YoY rise, while Wallester Business revenue doubled to €8.6M, reflecting an impressive 109% YoY growth.

Annualised Run Rate (ARR) also saw a significant boost, reaching €26.3M, representing a 98% YoY increase.

EBITDA surged from a deficit of €-0.5M to a positive €3.4M, marking an astonishing 800% YoY growth. Similarly, net profit increased dramatically from €-0.6M in 2023 to €2.3M in 2024, representing an extraordinary 457% YoY improvement. These financial metrics highlight the company's ability to navigate challenges while maintaining strong growth trajectories and enhancing profitability.

Geographic Expansion

One of the most notable events of 2024 occurred in March when the company received a cross-border activity license from the Estonian Financial Supervisory Authority (FSA), allowing the company to extend its services to the United Kingdom. As the first Estonian company to secure such a license post-Brexit, Wallester is uniquely positioned to tap into one of the world’s premier financial hubs. The UK team, led by CEO Julian Brand and supported by Group Chief Risk Officer Anna Maxim, is set to drive further success in this new market.

Meanwhile, Wallester continued its geographic expansion with the official opening of a new office in Riga, Latvia, in October. This move strengthens the company’s ability to serve clients in the Baltic region and beyond, enhancing its infrastructure and offering additional resources to fuel business growth.

Client Acquisition and Partnerships

The company also welcomed 2,250 new clients and issued over 1,000,000 cards during the year. These clients span diverse sectors, including travel businesses, payment service providers, large corporations, fintechs, governmental providers, and many others. The range and scale of industries reinforce the company’s unwavering belief in its market fit and leading position within the sector.

Award-Winning Year

Wallester was named the top startup in Estonia at the Äripäev TOP100 Gala, secured the 5th spot in the Sifted 30 Eastern Europe & Baltics Leaderboard, and was named the Best FinTech Partner at the 2024 FinTech Awards Europe and Best Enterprise Software Solution by SaaStock. The company also secured a spot on the iconic Estonian Mafia Wall of Fame at LIFT99 Tallinn Hub.

Looking Ahead to 2025

As we look towards 2025, plans are in place to expand its business to new countries, grow its team significantly, and bring in fresh ideas and experts to support its roadmap. Astafjev commented “Reflecting on 2024, I am filled with great pride at how our team dealt with numerous challenges and showed creativity and determination. We never stopped believing in our ability to deliver exceptional solutions. Thank you to every business that chose Wallester as their partner. We look forward to continuing our upward trajectory in 2025 and delivering even better results.”

What We Do

1. White-Label Solution with Embedded Finance

Our White-Label solution enables businesses to integrate financial services directly into their platforms—a concept known as embedded finance. This allows companies to launch branded payment cards tailored to their specific needs, enhancing customer experiences and opening new revenue streams. We ensure a swift time-to-market with simplified integration and dedicated support from our implementation team.

2. Wallester Business: Corporate Expense Management

Wallester Business is designed to modernise corporate expense management. It provides companies with instant access to virtual and physical Visa cards, streamlining financial processes through a modern app and comprehensive portal. Features include expense tracking, budget analytics, and seamless integration with accounting systems to enhance financial oversight and efficiency.

With a diverse team of over 140 professionals located in Estonia, Latvia, France and the UK, Wallester is dedicated to developing high-quality, profitable products for our clients. Our passion for innovation drives us to improve and adapt to the evolving financial landscape continuously.

About Wallester

Wallester is an Estonian-licensed financial institution and an official Visa partner since 2018, specialising in innovative digital financial solutions and card issuance. We empower companies across the European Economic Area (EEA) and the UK to streamline payments, launch branded cards, and scale efficiently. For more information, visit www.wallester.com.

Media Contact

Justin Zehmke
justin.zehmke@wallester.com
+372 5830 0375

March 26, 2025 11:04 AM

EDT

•

DAYTON, OH

Homeowners Control Their Home’s Online Presence with Unlisted

In today’s digital world, homeowners have little control over how their home appears on real estate platforms—until now. Unlisted, the world’s leading platform for off-market real estate, is the only real estate platform that allows homeowners to manage their home’s digital presence, ensuring their property is accurately represented, whether they’re selling soon or not.

Most real estate websites rely on old listing data and photos from when the home was sold by the previous owners, leaving the current homeowners with little control over how their home is presented online. Unlisted changes that by creating a customizable property profile for every home in the country. Homeowners have direct control over their property profile, allowing them to:

Add current photos: Upload high-quality images that truly reflect their home today.
Write their own description: Highlight their home’s best features and unique qualities in their own words.
Log home improvements and maintenance (coming soon): Keep track of upgrades, repairs, and key maintenance history—because homeowners deserve credit for being good stewards of their property.

“We live in a digital age. The ability to track and display accurate data about our most important asset, our home, translates to real value. If two homes are otherwise similar, but one has consistently updated their home data over time and the other hasn’t, the former is more desirable. We are empowering homeowners to drive the value for their property digitally, even if they’re not selling today,” says Katie Hill, founder and CEO of Unlisted.

By updating their home’s information on Unlisted, homeowners can gauge buyer interest and stay informed about potential demand, helping them feel prepared when the time comes to sell. Whether they’re simply exploring their options or considering an off-market sale, Unlisted gives them the insights they need—without the pressure of a public listing.

To learn more, please visit UnlistedHomes.com. To claim your home and update your property profile, visit UnlistedHomes.com/claim.

About Unlisted

Unlisted is an AI-powered real estate technology platform designed to reveal off-market property opportunities. By leveraging machine learning, the company creates more dynamic, efficient market opportunities for buyers, sellers, and real estate professionals. For more information, visit https://unlistedhomes.com.

Media Contact

Sophia Jacomet
sophia@unlistedinc.com

TuneHatch’s $1 Million Giveback to Independent Artists: Giving Control and Cash to its Musicians in 2025, Onward

TrialKit Launches AI-Powered Legal Discovery Platform, Secures $4.25M Seed Funding to Transform Criminal Defense

Quoin Reports Clinically Meaningful Whole Body Response to QRX003 in Pediatric Netherton Syndrome; Second Patient Cleared for Dosing

Exclusive: everle – A New Social Network Quietly Built to Heal the Digital World

Actor and Producer Charlie Day to Keynote 2025 OAAA OOH Media Conference as Full Agenda Goes Live

Kazakhstan’s EA Ventures and Plug and Play Launch €20 Million Fund to Support European Startups

Motorsport Meets the Future of Finance: CryptoProcessing by CoinsPaid Joins Forces with Eduardo and Fernando Barrichello

This Tape Measure App for Home Renovations Just Got Smarter: Preview Your Room Layout in 3D with Measure Tools – AR Ruler

NextNRG Announces Estimated 139% Year-over-Year Revenue Growth for February 2025

FineVPN Launches New VPN Service Using xRay Protocol for Enhanced Privacy and Security

First Class Action Lawsuit Filed Against University of Michigan for Massive Privacy Breach Affecting Thousands of Female Athletes

ValueTheMarkets Insights: While Big Pharma Stalls, One Small-Cap Breaks Out

ValueTheMarkets Insights: While Big Pharma Stalls, One Small-Cap Breaks Out

ValueTheMarkets Insights: Healthcare Climbs as Tech Stumbles in 2025 Shift

Miami AI Agent Summit Opens Registration, Hosted by Miami AI Hub and CrewAI

Hu Di, Business President of 58.com (Group), Named One of the 2025 Forbes China "20 Women to Watch in Business"

Michael VanPatten’s “Roswell Flying Crane over the Waterfalls” Selected for Prestigious Art of Georgia Exhibit

Omni, the First Crypto Wallet to Pioneer the Multi-Chain Web3 Experience, Acquired by Echo Base Holdings

Wallester Celebrates Record Growth in 2024

Homeowners Control Their Home’s Online Presence with Unlisted

Turn your news into performance